| Patents for C40B 30 - Methods of screening libraries (11,320) |
|---|
| 01/24/2013 | US20130023488 Methods and compounds for reducing intracellular lipid storage |
| 01/24/2013 | US20130023479 Use of nucleolin as a biomarker for lymphangiogenesis in cancer prognosis and therapy |
| 01/24/2013 | US20130023444 Color-producing diagnostic systems, reagents and methods |
| 01/24/2013 | US20130023443 Method for detecting pneumonia causative bacteria using nucleic acid chromatography |
| 01/24/2013 | US20130023442 Single nucleotide polymorphism for predicting recurrence of hepatocellular carcinoma |
| 01/24/2013 | US20130023441 Identification of Tumors |
| 01/24/2013 | US20130023440 Polynucleotides Associated With Age-Related Macular Degeneration and Methods for Evaluating Patient Risk |
| 01/24/2013 | US20130023439 Method and Kit for Determining Sensitivity to Decitabine Treatment |
| 01/24/2013 | US20130023438 Magnetic recovery method of magnetically responsive high-aspect ratio photoresist microstructures |
| 01/24/2013 | US20130023437 Diagnostic for lung disorders using class prediction |
| 01/24/2013 | US20130023436 Disease diagnosis and treatment using computational molecular phenotyping |
| 01/24/2013 | US20130023435 Sers-based analyte detection |
| 01/24/2013 | US20130023434 System and Method for Classification of Patients |
| 01/24/2013 | US20130023433 Methods of detecting nucleic acid sequences with high specificity |
| 01/24/2013 | US20130023432 Method for predicting therapeutic effect of immunotherapy on cancer patient and/or prognosis after immunotherapy, and gene set and kit to be used therin |
| 01/24/2013 | US20130023431 Methods of Assessing Chromosomal Instabilities |
| 01/24/2013 | US20130023430 Cancer stem cell gene variants are associated with tumor recurrence |
| 01/24/2013 | US20130023429 Transcription chip |
| 01/24/2013 | US20130023428 Biomarkers for neurological conditions |
| 01/24/2013 | US20130023427 Methods for assessing genomic instabilities in tumors |
| 01/24/2013 | US20130023426 Methods of Detecting Signatures of Disease or Conditions in Bodily Fluids |
| 01/24/2013 | US20130023425 Detecting pax2 for the diagnosis of breast cancer |
| 01/24/2013 | US20130023424 Detecting pax2 for the diagnosis of breast cancer |
| 01/24/2013 | US20130023423 Transposon nucleic acids comprising a calibration sequence for dna sequencing |
| 01/24/2013 | US20130023421 Protein display |
| 01/24/2013 | US20130023420 Susceptibility to hsp90-inhibitors |
| 01/24/2013 | US20130022664 E.coli lpfa antigen for prevention and treatment of infectious diseases |
| 01/24/2013 | US20130022622 Compounds for the treatment of autism |
| 01/24/2013 | US20130022620 Assays and methods pertaining to pre-amyloid intermediates |
| 01/24/2013 | US20130022597 Antibodies Directed To GPNMB And Uses Thereof |
| 01/24/2013 | US20130022596 Methods and compositions for diagnostic use in cancer patients |
| 01/24/2013 | US20130022593 Methods of diagnosing endometriosis |
| 01/24/2013 | US20130022582 Multipotent nestin-positive cells |
| 01/23/2013 | EP2548025A2 Using phage epitopes to profile the immune response |
| 01/23/2013 | EP2547809A1 Methods, probe sets, and kits for detection of deletion of tumor suppressor genes by fluorescence in situ hybridization |
| 01/23/2013 | CN102892934A Methods, probe sets, and kits for detection of deletion of tumor suppressor genes by fluorescence in situ hybridization |
| 01/22/2013 | US8357701 Galactokinase inhibitors |
| 01/17/2013 | WO2013010140A2 Methods of diagnosing cancer |
| 01/17/2013 | US20130019350 Methods and Compositions for Selecting Corn Plants Resistant to Diplodia Ear Rot |
| 01/17/2013 | US20130019327 Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted therein |
| 01/17/2013 | US20130019326 Compositions, Kits, and Methods for Identification, Assessment, Prevention, and Therapy of Metabolic Disorders |
| 01/17/2013 | US20130018175 Single variable domain antibodies against ox40l, constructs and therapeutic use |
| 01/17/2013 | US20130018087 miRNA Compounds for Treatment of Prostate Carcinoma |
| 01/17/2013 | US20130018060 Inhibitors of bruton's tyrosine kinase |
| 01/17/2013 | US20130018024 Methods and systems for pharmacogenomic treatment of cardiovascular conditions |
| 01/17/2013 | US20130018001 Methods of diagnosing cancer |
| 01/17/2013 | US20130017976 Methods and means for producing efficient silencing construct using recombinational cloning |
| 01/17/2013 | US20130017975 Single nucleotide polymorphism for predicting prognosis of hepatocellular carcinoma |
| 01/17/2013 | US20130017974 Methods and compositions relating to multiplex genomic gain and loss assays |
| 01/17/2013 | US20130017973 Functional molecule, functional molecule synthesizing amidite and target substance analysis method |
| 01/17/2013 | US20130017972 Method and compositions involving microrna |
| 01/17/2013 | US20130017971 Multivariate Diagnostic Assays and Methods for Using Same |
| 01/17/2013 | US20130017970 Biomarkers |
| 01/17/2013 | US20130017969 Markers and method for the diagnosis of rosacea |
| 01/17/2013 | US20130017968 Profiling of cell populations |
| 01/17/2013 | US20130017967 Nanofluidic biosensor and its use for rapid measurement of biomolecular interactions in solution and methods |
| 01/17/2013 | US20130017966 Methods for Genotyping with Selective Adaptor Ligation |
| 01/17/2013 | US20130017965 Osteoarthritis biomarkers and uses thereof |
| 01/17/2013 | US20130017964 Methods to Identify Chronic Lymphocytic Leukemia Disease Progression |
| 01/17/2013 | US20130017963 Method for determining surivival prognosis of patients suffering from non-small cell lung cancer (nsclc) |
| 01/17/2013 | US20130017962 Methods and compositions for correlating genetic markers with cardiovascular disease |
| 01/17/2013 | US20130017960 Products and processes for multiplex nucleic acid identification |
| 01/17/2013 | US20130017214 Bacteremia-associated antigen from staphylococcus aureus |
| 01/17/2013 | US20130017210 Display of antibody fragments on virus-like particles of rna bacteriophages |
| 01/17/2013 | DE102012013810B4 Nachweis von vermehrungsfähigen Zellen, die auf ein Erzeugnisgemisch reagieren Detection of viable cells that react to a product mixture |
| 01/17/2013 | CA2841335A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 01/15/2013 | CA2291853C Color-encoding and in-situ interrogation of matrix-coupled chemical compounds |
| 01/10/2013 | WO2013006857A1 Genetic alterations associated with autism and the autistic phenotype and methods of use thereof for the diagnosis and treatment of autism |
| 01/10/2013 | WO2012155123A3 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 01/10/2013 | US20130013334 Methods for the identification, assessment, and treatment of patients with cancer therapy |
| 01/10/2013 | US20130012604 Methods of using prdm1 genetic variants to prognose, diagnose and treat inflammatory bowel disease |
| 01/10/2013 | US20130012602 Methods of using znf365 genetic variants to diagnose crohn's disease |
| 01/10/2013 | US20130012550 Methods for prognosis and monitoring cancer therapy |
| 01/10/2013 | US20130012497 Methods for detecting adhd susceptibility and predicting severity and long term outcome of adhd symptoms |
| 01/10/2013 | US20130012435 Multivalent fibronectin based scaffold domain proteins |
| 01/10/2013 | US20130012414 Nanostructure based methods for detection structure determination separation transport extraction and control of chemical and biochemical material |
| 01/10/2013 | US20130012413 In vitro assays for enriching and determining the clonogenic potential of stem cells |
| 01/10/2013 | US20130012412 Marker for diagnosis of breast cancer, test method, and test kit |
| 01/10/2013 | US20130012411 Testing a patient population having a cardiovascular condition for drug efficacy |
| 01/10/2013 | US20130012410 Methods and materials for detecting colorectal cancer and adenoma |
| 01/10/2013 | US20130012409 Diagnostic and Prognostic Markers for Cancer |
| 01/10/2013 | US20130012408 Method for determination of onset risk of glaucoma |
| 01/10/2013 | US20130012407 Methods for predicting response of triple-negative breast cancer to therapy |
| 01/10/2013 | US20130012406 Methods and kits for multiplex amplification of short tandem repeat loci |
| 01/10/2013 | US20130012405 Circulating miRNA Biomaker Signatures |
| 01/10/2013 | US20130012404 Culture method, evaluation method and storage method for cancer-tissue-derived cell mass or aggregated cancer cell mass |
| 01/10/2013 | US20130012403 Compositions and Methods for Identifying Autism Spectrum Disorders |
| 01/10/2013 | US20130012402 Biomarkers |
| 01/10/2013 | US20130012401 Single nucleotide polymorphisms associated with dietary weight loss |
| 01/10/2013 | US20130012400 Method and device for separating molecular targets in a complex mixture |
| 01/10/2013 | US20130011918 Methods for telomere length and genomic dna quality control and analysis in pluripotent stem cells |
| 01/10/2013 | US20130011876 Process for preparing filamentous fungal strains having a sexual cycle and a process for preparing sexually crossed filamentous fungal strains |
| 01/10/2013 | US20130011496 Cancer testis antigens as biomarkers in non-small cell lung cancer |
| 01/10/2013 | US20130011428 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/10/2013 | US20130011409 Compositions, Kits, and Methods for the Diagnosis, Prognosis, Monitoring, Treatment and Modulation of Post-Transplant Lymphoproliferative Disorders and Hypoxia Associated Angiogenesis Disorders Using Galectin-1 |
| 01/10/2013 | US20130011395 Methods and compositions for treating autoimmune diseases or conditions |
| 01/10/2013 | US20130011393 Bad pathway gene signature |
| 01/08/2013 | US8349619 Method for detecting and analyzing protein interactions in-vivo |
| 01/08/2013 | CA2707765C Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample |
| 01/08/2013 | CA2606156C Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers |